These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 13665126)

  • 1. The role of peripheral venous congestion in the maintenance of sustained plasma quinidine level.
    ROSENBERG SZ; STERN S; HEIMANNHOLLAENDER E
    J Lab Clin Med; 1959 Jun; 53(6):849-53. PubMed ID: 13665126
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Elimination of quinidine in congestive heart failure.
    Crouthamel WG
    N Engl J Med; 1974 Jun; 290(24):1379-80. PubMed ID: 4827650
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of quinidine in dogs with congestive cardiac failure.
    Jellett LB; Lloyd BL; Taylor RR; Ilett KF
    Pharmacol Res Commun; 1977 May; 9(5):455-63. PubMed ID: 882589
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on methods of assaying, and the value of monitoring plasma quinidine concentrations.
    Abramson FP; Yago KB; Feuillan P
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):631-4. PubMed ID: 461980
    [No Abstract]   [Full Text] [Related]  

  • 5. Quinidine kinetics in congestive heart failure.
    Ueda CT; Dzindzio BS
    Clin Pharmacol Ther; 1978 Feb; 23(2):158-64. PubMed ID: 620475
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood collection techniques, heparin and quinidine protein binding.
    Kessler KM; Leech RC; Spann JF
    Clin Pharmacol Ther; 1979 Feb; 25(2):204-10. PubMed ID: 759074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state serum quinidine concentration: role in prophylactic therapy following acute myocardial infarction.
    Halkin H; Vered Z; Millman P; Rabinowitz B; Neufeld HN
    Isr J Med Sci; 1979 Jul; 15(7):583-7. PubMed ID: 478822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiohemodynamic effects of venous congestion of the legs or of phlebotomy in patients with and without congestive heart failure.
    JUDSON WE; HOLLANDER W; HATCHER JD; HALPERIN MH; FRIEDMAN IH
    J Clin Invest; 1955 Apr; 34(4):614-21. PubMed ID: 14367515
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinidine elimination in patients with congestive heart failure or poor renal function.
    Kessler KM; Lowenthal DT; Warner H; Gibson T; Briggs W; Reidenberg MM
    N Engl J Med; 1974 Mar; 290(13):706-9. PubMed ID: 4813743
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of venous congestion of the heart in chronic cardiac decompensation and in the development of collateral coronary arterial circulation].
    TEMESVARI A; KUNOS I
    Magy Belorv Arch Ideggyogy Szle; 1954 Jun; 7(3):91-3. PubMed ID: 13222979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of plasma quinidine during quinidine therapy].
    Maagoe H
    Nord Med; 1971 Nov; 86(45):1312. PubMed ID: 5117781
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction.
    Parrinello G; Torres D; Testani JM; Almasio PL; Bellanca M; Pizzo G; Cuttitta F; Pinto A; Butler J; Paterna S
    Intern Emerg Med; 2015 Dec; 10(8):965-72. PubMed ID: 26037394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of plasma pH on quinidine uptake by erythrocytes: estimation of free drug fraction in plasma from blood/and erythrocyte/plasma concentration ratios.
    Ho Ngoc-Ta Trung A; Sirois G
    Pharm Acta Helv; 1987; 62(2):61-4. PubMed ID: 3575343
    [No Abstract]   [Full Text] [Related]  

  • 14. Impairment of the enzymatic inactivation of adrenal cortical hormones following passive venous congestion of the liver.
    YATES FE; URQUHART J; HERBST AL
    Am J Physiol; 1958 Jul; 194(1):65-71. PubMed ID: 13559430
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interaction of digoxin and quinidine].
    Haustein KO; Oltmanns G
    Z Gesamte Inn Med; 1980 Feb; 35(4):186-7. PubMed ID: 7405308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Average steady-state plasma levels with slow release quinidine preparations].
    Normand JP; Roux A; Bardet J; Kahn JC; Maspoli JJ; Jarreau FX; Sansarricq M; Flouvat B; Bourdarias JP
    Arch Mal Coeur Vaiss; 1979 Sep; 72(9):1006-13. PubMed ID: 116611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum quinidine levels after chronic administration of four different quinidine formulations.
    Soeterboek AM; Van Thiel M; Eng C
    J Int Med Res; 1976; 4(6):393-401. PubMed ID: 1027633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein binding of salicylate and quinidine in patients with multiple myeloma.
    Perez-Mateo M; Erill S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):168-70. PubMed ID: 447437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
    Zinny MA; Taggart WV
    Clin Ther; 1984; 7(1):22-7. PubMed ID: 6518461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma level studies of quinidine retard, their significance for dosage and onset of effect].
    Guckenbiehl W; Just H; Olbermann M; Lang KF
    Med Klin; 1976 Apr; 71(14):586-92. PubMed ID: 57566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.